@0xtechquity Agreed. $RMD also uses classic razor&blade biz model—sell CPAP hardware once, then generate continuous rev from high-margin replacements like masks, tubing, & filters. And its cloud-connected devices are greatly increasing CPAP use adherence.
@Ashton_1nvests The only misunderstood biz here in my view is perhaps the least obvious misunderstood: $MA. The market freaks out about regulation and network/interchange fees, ignoring that VAS is growing +20% each quarter, +40% revenue, is stickier & free from the same type of regulation
@WillBiddy_ Wide moat but mostly transactional biz and has made some poor acquisitions. While also transactional and narrow moat, prefer $CBOE for largest options exchange, consistently higher growth, runway, and great new CEO at the helm (former CME CEO actually).
@FinanceTiger@DutchInvestors Except Adyen just beat out—actually not beat out, unseated—Stripe as the fintech for UK government
https://t.co/ZaVOiaXizh
@davey_juice I don’t necessarily think it’s easy to replicate and displace but monetizing via advertising is fleeting, there’s too much potential controversy, so my conclusion is the same as yours.